Microtest Laboratories has issued a management brief that discusses the FDA’s proposed changes to 21 CFR 610, which currently requires the use of a culture-based method in evaluating sterility for biological products.
Read the full report in Becker’s Hospital Review on proposed changes to sterility testing.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
